Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, July 02, 2015 12:54:02 PM
bullish
## source: finance.yahoo.com
Mon, 22 Jun 2015 12:38:00 GMT ~ Small Cap Stocks Fueled By Favorable Funding Deals
[Accesswire] - CORAL GABLES, FL / ACCESSWIRE / June 22, 2015 / Investors sometimes forget that companies go public to take advantage of capital markets in order to fund operations and push forward for new development. ...
read full: http://finance.yahoo.com/news/small-cap-stocks-fueled-favorable-123800806.html
*********************************************************
Thu, 18 Jun 2015 16:30:00 GMT ~ 5 Stocks Under $10 Set to Soar
read full: http://www.thestreet.com/story/13191713/1/5-stocks-under-10-set-to-soar.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Mon, 11 May 2015 12:54:55 GMT ~ Coronado reports 1Q loss
read full: http://sg.finance.yahoo.com/news/coronado-reports-1q-loss-125455413.html
*********************************************************
Mon, 11 May 2015 12:54:55 GMT ~ Coronado reports 1Q loss
read full: http://finance.yahoo.com/news/coronado-reports-1q-loss-125455654.html
*********************************************************
Mon, 11 May 2015 12:30:00 GMT ~ Fortress Biotech Reports Financial Results for the First Quarter 2015 Ended March 31, 2015
[GlobeNewswire] - NEW YORK -- Fortress Biotech, Inc. announces its financial results for the first quarter of 2015 ended March 31, 2015.
read full: http://finance.yahoo.com/news/fortress-biotech-reports-financial-results-123000825.html
*********************************************************
$FBIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$FBIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/FBIO/company-info
Ticker: $FBIO
OTC Market Place: Not Available
CIK code: 0001429260
Company name: Fortress Biotech, Inc.
Company website: http://www.coronadobiosciences.com
Incorporated In: DE, USA
Business Description: We are a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of inflammatory diseases and cancer.
$FBIO share structure
## source: otcmarkets.com
Market Value: $155,770,126 a/o Jul 01, 2015
Shares Outstanding: 46,498,545 a/o Mar 13, 2015
Float: Not Available
Authorized Shares: 50,000,000 a/o Sep 30, 2011
Par Value: 0.001
$FBIO extra dd links
Company name: Fortress Biotech, Inc.
Company website: http://www.coronadobiosciences.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FBIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/news - http://finance.yahoo.com/q/h?s=FBIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Fortress+Biotech%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Fortress+Biotech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Fortress+Biotech%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.coronadobiosciences.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.coronadobiosciences.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.coronadobiosciences.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001429260&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FBIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FBIO
$FBIO DD Notes ~ http://www.ddnotesmaker.com/FBIO
Recent FBIO News
- Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 05/13/2024 08:01:47 PM
- Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 • GlobeNewswire Inc. • 05/07/2024 12:30:10 PM
- Mustang Bio Announces Closing of $4 Million Public Offering • GlobeNewswire Inc. • 05/02/2024 08:01:07 PM
- Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer • GlobeNewswire Inc. • 05/01/2024 08:01:30 PM
- Mustang Bio Announces Pricing of $4 Million Public Offering • GlobeNewswire Inc. • 04/30/2024 12:00:07 AM
- Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds • GlobeNewswire Inc. • 04/29/2024 12:00:14 PM
- Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 • GlobeNewswire Inc. • 04/25/2024 12:30:48 PM
- Avenue Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 04/24/2024 11:30:41 AM
- Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/28/2024 08:05:13 PM
- Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases • GlobeNewswire Inc. • 03/28/2024 01:00:51 PM
- Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/21/2024 08:01:27 PM
- Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/18/2024 08:05:14 PM
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea • GlobeNewswire Inc. • 03/18/2024 12:30:30 PM
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 12:30:01 PM
- Avenue Therapeutics Receives Positive Listing Determination from Nasdaq • GlobeNewswire Inc. • 03/15/2024 12:15:01 PM
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/13/2024 12:30:14 PM
- Fortress Biotech to Participate in 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/12/2024 12:30:16 PM
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:30:30 PM
- Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:00:17 PM
- Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma • GlobeNewswire Inc. • 03/07/2024 12:30:12 PM
- Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease • GlobeNewswire Inc. • 03/04/2024 01:30:24 PM
- Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy • GlobeNewswire Inc. • 02/22/2024 01:30:08 PM
- Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/11/2024 01:30:39 PM
- Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference • GlobeNewswire Inc. • 01/11/2024 01:00:08 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM